These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19533034)

  • 21. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new mechanism for transmissible prion diseases.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
    J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
    Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
    Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes.
    Chu NK; Shabbir W; Bove-Fenderson E; Araman C; Lemmens-Gruber R; Harris DA; Becker CF
    J Biol Chem; 2014 Oct; 289(43):30144-60. PubMed ID: 25217642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the 132-160 region in prion protein conformational transitions.
    Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
    Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The roles of the conserved tyrosine in the β2-α2 loop of the prion protein.
    Huang D; Caflisch A
    Prion; 2015; 9(6):412-9. PubMed ID: 26689486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.
    Groveman BR; Dolan MA; Taubner LM; Kraus A; Wickner RB; Caughey B
    J Biol Chem; 2014 Aug; 289(35):24129-42. PubMed ID: 25028516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparan sulfate is a cellular receptor for purified infectious prions.
    Horonchik L; Tzaban S; Ben-Zaken O; Yedidia Y; Rouvinski A; Papy-Garcia D; Barritault D; Vlodavsky I; Taraboulos A
    J Biol Chem; 2005 Apr; 280(17):17062-7. PubMed ID: 15668247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity.
    Kourie JI
    Chem Biol Interact; 2001 Oct; 138(1):1-26. PubMed ID: 11640912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease.
    Friedman-Levi Y; Mizrahi M; Frid K; Binyamin O; Gabizon R
    PLoS One; 2013; 8(7):e69583. PubMed ID: 23922744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
    Sang JC; Lee CY; Luh FY; Huang YW; Chiang YW; Chen RP
    Prion; 2012; 6(5):489-97. PubMed ID: 22987112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian prions: tolerance to sequence changes-how far?
    Salamat MK; Munoz-Montesino C; Moudjou M; Rezaei H; Laude H; Béringue V; Dron M
    Prion; 2013; 7(2):131-5. PubMed ID: 23232499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of cell-surface prion protein relative to its recombinant analogue: insights from molecular dynamics simulations of diglycosylated, membrane-bound human prion protein.
    DeMarco ML; Daggett V
    J Neurochem; 2009 Apr; 109(1):60-73. PubMed ID: 19226372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the flexible amino-terminal domain of prion protein bound to a sulfated glycan.
    Taubner LM; Bienkiewicz EA; Copié V; Caughey B
    J Mol Biol; 2010 Jan; 395(3):475-90. PubMed ID: 19913031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion neurotoxicity: insights from prion protein mutants.
    Solomon IH; Schepker JA; Harris DA
    Curr Issues Mol Biol; 2010; 12(2):51-61. PubMed ID: 19767650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structural characterization of a mimetic membrane-anchored prion protein.
    Hicks MR; Gill AC; Bath IK; Rullay AK; Sylvester ID; Crout DH; Pinheiro TJ
    FEBS J; 2006 Mar; 273(6):1285-99. PubMed ID: 16519692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
    Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
    Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.